>
Enzo BiochemEnzo Biochem
Enzo旗下共有Enzo,Biomol,Alexis Biochemicals,AssayDesigns,Stressgen等品牌,為生命科學(xué)研究者提供基因組分析,細(xì)胞生物學(xué),翻譯后修飾,信號(hào)轉(zhuǎn)導(dǎo),腫瘤和免疫學(xué),藥物篩選等相關(guān)領(lǐng)域的優(yōu)質(zhì)產(chǎn)品。Enzolife sciences 的標(biāo)記技術(shù)和檢測(cè)技術(shù)在科學(xué)研究和臨床診斷這兩個(gè)領(lǐng)域中處于領(lǐng)先地位。標(biāo)記探針和染料的強(qiáng)強(qiáng)組合是基因表達(dá)分析,核酸檢測(cè),蛋白質(zhì)生物化學(xué)研究與檢測(cè),分子生物學(xué),細(xì)胞分析等研究領(lǐng)域中目標(biāo)識(shí)別/驗(yàn)證和高容量分析實(shí)驗(yàn)的強(qiáng)有力工具。
Enzo Biochem是分子診斷的先驅(qū),通過(guò)開發(fā)獨(dú)特的診斷平臺(tái)技術(shù),提供了優(yōu)于以前標(biāo)準(zhǔn)的許多優(yōu)勢(shì),從而引領(lǐng)臨床實(shí)驗(yàn)室,生命科學(xué)和治療學(xué)的融合。作為一家全球性公司,Enzo Biochem利用跨職能團(tuán)隊(duì)開發(fā)和部署產(chǎn)品系統(tǒng)和服務(wù),以滿足當(dāng)今和未來(lái)醫(yī)療保健不斷變化和快速增長(zhǎng)的需求。支持Enzo Biochem的技術(shù),平臺(tái)和產(chǎn)品是一個(gè)廣泛而深入的知識(shí)產(chǎn)權(quán)組合,專利覆蓋了許多關(guān)鍵的支持技術(shù)。
Enzo Biochem is a leading life sciences and biotechnology company focused on harnessing genetic processes to develop research tools, diagnostics and therapeutics and provides reference laboratory services to the medical community. Founded in 1976, we have concentrated on the development of enabling technologies in the areas of gene regulation and gene modification. Many of our technologies are applicable to the biomedical and pharmaceutical research markets, and we are further using these technologies as a platform for our entry into the clinical diagnostics market. Today, Enzo technologies and products are recognized as the key tools in non-radioactive gene labeling used by researchers worldwide. Additionally, Enzo's work in gene analysis has led to development of a number of significant therapeutic candidates for the treatment of viral and immunological based disorders, several of which are in various phases of human clinical trials. In the course of our extensive research and development activities, we have built a significant patent position consisting of numerous pioneer patents and applications that encompass our core technologies.
The business activities of Enzo Biochem are performed by the company's three wholly owned subsidiaries . . . Enzo Life Sciences, Enzo Therapeutics and Enzo Clinical Labs. Such activities include research and development, manufacturing and marketing of biomedical research products and tools through Enzo Life Sciences and research and development of therapeutic products through Enzo Therapeutics and the operation of a regional clinical reference laboratory through Enzo Clinical Labs.
產(chǎn)品列表:
Enzo Biochem | BioArray(tm) HighYield(tm) RNA Transcript Labeling Kit (T7) | 10 reactions |
Enzo Biochem | BioArray(tm) Eukaryotic Hybridization Controls | 150 reactions |
Enzo Biochem | BioArray(tm) Deoxyoligo B2 | 150 reactions |
Enzo Biochem | Single Round Amplification and Labeling Systems | NA |
Enzo Biochem | Array CGH Labeling Kits | 1 KT |
Enzo Biochem | Cyanine 5-NHS Ester Pack | NA |
Enzo Biochem | Direct Labeling of cDNA | NA |
Enzo Biochem | Cyanine-5-dUTP | 25mmol |
Enzo Biochem | Cyanine-5-UTP | NA |
Enzo Biochem | Modified Nucleotides | NA |
Enzo Biochem | Indirect Labeling Reactive Dye Packs | NA |
Enzo Biochem | Ribonucleotides | NA |
Enzo Biochem | Bio-17-ATP | 250mmol' |
Enzo Biochem | Fluorescein-12-UTP | 250mmol' |
Enzo Biochem | Bio-11-dCTP | 50mmol |